^
BIOMARKER:
EGFR expression
i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
EGFR expression
Lung Non-Small Cell Squamous Cancer
necitumumab
Sensitive
:
A1
EGFR expression
CRC
cetuximab
Sensitive
:
A1
EGFR expression
Chordoma
lapatinib
Sensitive
:
A2
EGFR expression
NSCLC
erlotinib + ramucirumab
Sensitive
:
A2
EGFR expression
NSCLC
erlotinib
Sensitive
:
B
EGFR expression
CRC
panitumumab
Sensitive
:
B
EGFR expression
HER2 Positive Breast Cancer
ado-trastuzumab emtansine
Sensitive
:
B
EGFR expression
NSCLC
gefitinib
Sensitive
:
B
EGFR expression
SCCHN
cetuximab
Sensitive
:
C1
EGFR expression
NSCLC
durvalumab
Sensitive
:
C2
EGFR expression
Ovarian Cancer
gefitinib
Resistant
:
C2
EGFR expression
NSCLC
sintilimab
Sensitive
:
C3
EGFR expression
NSCLC
PD-L1 inhibitor
Resistant
:
C3
EGFR expression
Pancreatic Adenocarcinoma
trastuzumab + erlotinib
Sensitive
:
C3
EGFR expression
NSCLC
osimertinib
Sensitive
:
C3
EGFR expression
Lung Non-Squamous Non-Small Cell Cancer
gefitinib + fulvestrant
Sensitive
:
C3
EGFR expression
LUAD
Tyrosine kinase inhibitor
Sensitive
:
C3
EGFR expression
NSCLC
anlotinib + APL-502
Sensitive
:
C3
EGFR expression
LUAD
afatinib
Sensitive
:
C4
EGFR expression
GBM
paclitaxel
Sensitive
:
D
EGFR expression
GBM
selumetinib
Sensitive
:
D
EGFR expression
Glioma
gefitinib
Sensitive
:
D
EGFR expression
SCCHN
vandetanib
Sensitive
:
D
EGFR expression
Pancreatic Cancer
afatinib
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our